Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.07 USD | -2.08% | -10.51% | -10.28% |
May. 28 | Outlook Therapeutics Granted EU Marketing Authorization for Lytenava to Treat Wet AMD | MT |
May. 21 | CoStar Group has room for expansion |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 9.52M | Capitalization | 165M |
---|---|---|---|---|---|
Net income 2024 * | -121M | Net income 2025 * | -66M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 17.4 x |
P/E ratio 2024 * |
-1.26
x | P/E ratio 2025 * |
-3.17
x | Employees | 24 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.99% |
Latest transcript on Outlook Therapeutics, Inc.
1 day | -2.08% | ||
1 week | -10.51% | ||
1 month | -20.74% | ||
3 months | -19.07% | ||
6 months | -26.35% | ||
Current year | -10.28% |
Managers | Title | Age | Since |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 21-07-06 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15-09-14 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 23-01-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 18-04-12 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 15-12-10 |
C. Trenary
CEO | Chief Executive Officer | 66 | 21-07-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +9.86% | - | |
0.00% | 17 M€ | +4.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 7.07 | -2.08% | 166,605 |
24-05-30 | 7.22 | +1.26% | 233,461 |
24-05-29 | 7.13 | -10.14% | 256,835 |
24-05-28 | 7.935 | +0.44% | 661,628 |
24-05-24 | 7.9 | +4.91% | 228,601 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.28% | 169M | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- OTLK Stock